Drugs / cNP8
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06223009 | Jan → May 2024 | — | Neomatrix Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cNP8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06223009 ↗ |
| Route | Intravenous | “single 30 minute IV infusion of cNP8” NCT06223009 ↗ |